Kalincik, T. Et Al. 2020. Immunotherapies Improve Long-Term Disability Outcomes in Relapsing-Remitting Multiple Sclerosis. Annual Meeting of the American-Academy-of-Neurology , (Toronto, Canada).

Kalincik, T., Ibrahima, D., Malpas, C., Horakova, D., Havrdova, E., Trojano, M., ... Ayuso, G.(2020). Immunotherapies Improve Long-Term Disability Outcomes in Relapsing-Remitting Multiple Sclerosis . Annual Meeting of the American-Academy-of-Neurology, Toronto, Canada

Kalincik, Tomas Et Al. "Immunotherapies Improve Long-Term Disability Outcomes in Relapsing-Remitting Multiple Sclerosis," Annual Meeting of the American-Academy-of-Neurology, Toronto, Canada, 2020

Kalincik, Tomas Et Al. "Immunotherapies Improve Long-Term Disability Outcomes in Relapsing-Remitting Multiple Sclerosis." Annual Meeting of the American-Academy-of-Neurology , Toronto, Canada, 2020

Kalincik, T. Et Al. (2020) . "Immunotherapies Improve Long-Term Disability Outcomes in Relapsing-Remitting Multiple Sclerosis." Annual Meeting of the American-Academy-of-Neurology , Toronto, Canada.

@conferencepaper{conferencepaper, author={Tomas Kalincik Et Al. }, title={Immunotherapies Improve Long-Term Disability Outcomes in Relapsing-Remitting Multiple Sclerosis}, congress name={Annual Meeting of the American-Academy-of-Neurology}, city={Toronto}, country={Canada}, year={2020}}